Joseph W Rossano
Overview
Explore the profile of Joseph W Rossano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
228
Citations
4299
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ostrominski J, Claggett B, Jerosch-Herold M, Raja A, Day S, Russell M, et al.
JAMA Cardiol
. 2025 Mar;
PMID: 40042824
Importance: Valsartan has been shown to attenuate phenotypic progression among individuals with early-stage sarcomeric hypertrophic cardiomyopathy (HCM). Myocardial tissue characterization by cardiac magnetic resonance (CMR) imaging may enhance mechanistic insights,...
2.
Butters A, Arnott C, Sweeting J, Claggett B, Cuomo A, Cuomo A, et al.
Circ Genom Precis Med
. 2025 Jan;
18(1):e004641.
PMID: 39851041
Background: Females with hypertrophic cardiomyopathy present at a more advanced stage of the disease and have a higher risk of heart failure and death. The factors behind these differences are...
3.
Griffiths E, Profsky M, Mokshagundam D, Boucek K, Amdani S, Davies R, et al.
Ann Thorac Surg
. 2025 Jan;
119(3):513-522.
PMID: 39818264
Background: The Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs), supported by The Society of Thoracic Surgeons, provides detailed information on pediatric patients supported with ventricular assist devices (VADs). Methods:...
4.
Alshawabkeh L, Herrick N, Opotowsky A, Singh T, Landzberg M, Urey M, et al.
Int J Cardiol Congenit Heart Dis
. 2024 Dec;
14:100474.
PMID: 39712990
[This corrects the article DOI: 10.1016/j.ijcchd.2022.100384.].
5.
Alshawabkeh L, Herrick N, Opotowsky A, Singh T, Landzberg M, Urey M, et al.
Int J Cardiol Congenit Heart Dis
. 2024 Dec;
8:100384.
PMID: 39712045
Introduction: The number of heart transplants in adults with congenital heart disease (CHD) is increasing, though outcomes remain unfavorable compared to those without CHD. The etiology of this mortality difference...
6.
Meisner J, Renberg A, Smith E, Tsan Y, Elder B, Bullard A, et al.
Circulation
. 2024 Dec;
PMID: 39633578
Background: Classically, hypertrophic cardiomyopathy (HCM) has been viewed as a single-gene (monogenic) disease caused by pathogenic variants in sarcomere genes. Pathogenic sarcomere variants are individually rare and convey high risk...
7.
Greenberg B, Taylor M, Adler E, Colan S, Ricks D, Yarabe P, et al.
N Engl J Med
. 2024 Nov;
392(10):972-983.
PMID: 39556016
Background: Danon disease is a rare, X-linked, monogenic cardiomyopathy caused by mutations in the lysosomal-associated membrane 2 gene (), which encodes the LAMP2 protein. In male patients, the predominant phenotype...
8.
Ahluwalia M, Liu J, Olivotto I, Parikh V, Ashley E, Michels M, et al.
JACC Heart Fail
. 2024 Nov;
13(2):332-343.
PMID: 39520446
Background: An improved understanding of the natural history in NYHA functional class I patients with obstructive hypertrophic cardiomyopathy (oHCM) is needed. Objectives: Using a multicenter registry (SHaRe [Sarcomeric Human Cardiomyopathy...
9.
Lorts A, VanderPluym C, Adachi I, Perry T, Alexander P, Almond C, et al.
ASAIO J
. 2024 Sep;
70(11):911-919.
PMID: 39330959
Adverse events (AEs) experienced by children and adults with congenital heart disease (CHD) on ventricular assist devices (VADs) are sometimes unique to these populations. The Advanced Cardiac Therapies Improving Outcomes...
10.
Shustak R, Rossano J
JAMA Netw Open
. 2024 Sep;
7(9):e2434648.
PMID: 39302681
No abstract available.